3 Top Biotech ETFs For Q2
Of the dozen or so biotech ETFs that trade in the U.S., these three may be the best picks for Q2. CLICK HERE.
Of the dozen or so biotech ETFs that trade in the U.S., these three may be the best picks for Q2. CLICK HERE.
Radiation, surgery, chemotherapy…and electric fields? This oncology company has developed a fourth paradigm for treating cancer – and has multiple data readouts this year that… Read More »A Cancer Play With A New Treatment Paradigm – And Multiple Data Readouts This Year
As has been on full display in recent weeks, developing an effective vaccine is one thing. Rolling it out efficiently is another. As one tech/industrial… Read More »A Way To Play This Vaccine Rollout Partnership
What are the best large biotech stocks to buy now? Based on hedge fund sentiment data, these are the top 12. CLICK HERE.
From prominent names such as Moderna to smaller newcomers such as Tyme Technologies to emerging market players such as Indian biotech Cipla, here are some… Read More »The Big Names, Smaller Newcomers, And Emerging Market Players In The Race For A COVID Cure
Within the universe of large, established drug and biotech companies, there are limited options for big upside. One major exception to this rule of limited… Read More »One Major Exception To The Limited Upside Among Established Drug And Biotech Stocks
As the race for a coronavirus vaccine heats up, biotech stocks are on fire. And traders are sharing their strategies for – and best bets… Read More »Strategies For The Biotech Surge
While it could be a year or more before a vaccine for the new coronavirus is ready for market, significant progress in the development of… Read More »This Biotech Is Experiencing A Coronavirus Surge
Amid the panic over the new coronavirus that has led to unprecedented quarantines in China, and which has now made its way to North America,… Read More »Panic Potential
Last year, this biotech firm had a $50 stock and $3 billion market cap. Today, it has a stock trading below $16 and a market… Read More »A Treatment That Improves The Condition Of MS Patients Could Improve The Condition Of This Beaten-Up Biotech